Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users

Objective The aim of the present study was to measure the treatment of menorrhagia and health-related quality of life (QoL) in Levonorgestrel-releasing intrauterine system (LNG-IUS) in Turkish women.

We recruited 66 premenopausal women, aged 26–55 years, who had sought care in the previous year for menorrhagia. All patients were asked to complete a visual analog scale (VAS) form regarding pelvic pain, sexual life (libido) and general feeling of health. Patients filled the VAS form before LNG-IUS insertion and after 6 months.

After the 6-month visit, PBAC score was condirebly decreased (p < 0.001). Six (10%) of the 60 patients PBAC score was higher than 75. VAS score for pelvic pain decreased from baseline to 6-month follow-up (4.32–3.55), and the libido and general feeling of health increased (4.27–4.95 and 3.47–6.87, respectively).

The LNG-IUS device in the trearment of menorrhagia has cost effective, less side effects and increse in the QoL. Similar content being viewed by others

Hurskainen R, Paavonen J (2004) Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding. Curr Opin Obstet Gynecol 16:487–490. doi:10.1097/00001703-200412000-00009 Chrisman C, Ribeiro P, Dalton VK (2007) The Levonorgestrel-releasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses. Clin Obstet Gynecol 50(4):886–897 Lethaby AE, Cooke I, Rees M (2005) Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev CD002126 Higham JM, O’Brien PMS, Shaw RW (1990) Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 97:734–739 Guyatt GH, Cook DJ (1994) Health status, quality of life, and the individual. JAMA 272(8):630–631. doi:10.1001/jama.272.8.630 Jenkinson C, Peto V, Coulter A (1994) Measuring change over time: a comparison of results from a global single item of health status and the multi-dimensional SF-36 health status survey questionnaire in patients presenting with menorrhagia. Qual Life Res 3:317–321. doi:10.1007/BF00451723 Keshavarz H, Hillis SD, Kieke BA, Marchbanks PA (2002) Hysterectomy surveillance—United States, 1994–1999. MMWR CDC Surveill Summ 51:1–8 Clarke A, Black N, Rowe P, Mott S, Howie K (1995) Indications for and outcomes of total abdominal hysterectomy for benign disease; a prospective cohort study. Br J Obstet Gynaecol 102:611–620 Dwyer N, Hutton J, Stirrat GM (1993) Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorraghia. Br J Obstet Gynaecol 100:237–243 Sculpher MJ, Dwyer N, Byford S, Stirrat GM (1996) Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery. Br J Obstet Gynaecol 103:142–149 Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivela A et al (2001) Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 357:273–277. doi:10.1016/S0140-6736(00)03615-1 Coulter A, Peto V, Jenkinson C (1994) Quality of life and patient satisfaction following treatment for menorrhagia. Fam Pract 11:394–401. doi:10.1093/fampra/11.4.394 Shankar M, Kadir RA (2008) Review of quality of life: menorrhagia in women with or without inherited bleeding disorders. Haemophilia 14:15–20 Myers ER, Steege JF (1999) Risk adjustment for complications of hysterectomy: limitations of routinely collected administrative data. Am J Obstet Gynecol 181:567–575. doi:10.1016/S0002-9378(99)70494-1 Inki P (2007) Long-term use of the levonorgestrel-releasing intrauterine system. Contraception 75:161–166. doi:10.1016/j.contraception.2006.12.016 National Collaborating Centre for Women’s and Children’s Health (NICE) Heavy menstrual bleeding. Published by the RCOG Press at the Royal Collage of Obstetricians and Gynaecologists, London. www.rcog.org.uk Hurskainen R (2006) Managing drug-resistant essential menorrhagia without hysterectomy. Best Pract Res Clin Obstet Gynaecol 20(5):681–694. doi:10.1016/j.bpobgyn.2006.03.003 Bourdrez P, Bongers MY, Mol BWJ (2004) Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrelreleasing intrauterine device, or hysterectomy. Fertil Steril 82:160–166. doi:10.1016/j.fertnstert.2003.12.025 Vuorma S, Teperi J, Hurskainen R, Aalto AM, Rissanen P, Kujansuu E (2003) Correlates of women’s preferences for treatment of heavy menstrual bleeding. Patient Educ Couns 49(2):125–132. doi:10.1016/S0738-3991(02)00069-1 Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Ann Intern Med 118(8):622–629 Conflict of interest statement The authors stated that they had no interests which might be perceived as posing a conflict or bias. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Gorgen, H., Api, M., Akça, A. et al. Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users. Arch Gynecol Obstet 279, 835–840 (2009). https://doi.org/10.1007/s00404-008-0834-x Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00404-008-0834-x